(Q38205725)

31 August 2017

title

Adverse drug reaction reporting by patients: an overview of fifty countries (English)

1 reference

31 August 2017

Florence Margraff

1

1 reference

31 August 2017

Delphine Bertram

series ordinal

2

1 reference

31 August 2017

publication date

1 June 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

37

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

409-419

1 reference

Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals.

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Adverse drug reaction reporting by patients in the Netherlands: three years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Experiences with adverse drug reaction reporting by patients: an 11-country survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

The missing voice of patients in drug-safety reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Web-scale pharmacovigilance: listening to signals from the crowd

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

What motivates patients to report an adverse drug reaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Pharmacovigilance Regulatory Requirements in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Specific features of medicines safety and pharmacovigilance in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

The Erice declaration : the critical role of communication in drug safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Low awareness of adverse drug reaction reporting systems: a consumer survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

21 January 2018

Guide to pharmacology

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-014-0162-Y

Comparative evaluation of adverse drug reaction reporting forms for introduction of a spontaneous generic ADR form

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24748428

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40264-014-0162-Y

1 reference

Dimensions Publication ID

31 August 2017

1034648980

0 references

1 reference